Lumos Pharma, Inc.
LUMO · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$31 | -$30 | -$6 |
| Dep. & Amort. | $0 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | -$10 |
| Stock-Based Comp. | $2 | $2 | $3 | $1 |
| Change in WC | $1 | $2 | -$2 | -$4 |
| Other Non-Cash | -$0 | -$0 | $0 | -$6 |
| Operating Cash Flow | -$31 | -$27 | -$30 | -$23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $84 |
| Inv. Purchases | -$7 | -$11 | $0 | $0 |
| Inv. Sales/Matur. | $18 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$11 | $26 | $33 |
| Investing Cash Flow | $11 | -$11 | $26 | $117 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$0 |
| Stock Issued | $1 | $0 | -$0 | $117 |
| Stock Repurch. | -$1 | -$1 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | -$0 | $0 |
| Financing Cash Flow | -$1 | -$1 | -$0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$21 | -$39 | -$4 | $94 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56 | $95 | $99 | $5 |
| End Cash | $35 | $56 | $95 | $99 |
| Free Cash Flow | -$31 | -$27 | -$30 | -$23 |